Paediatric Oncology Therapeutics Market

Children are affected by different forms of cancer than adults, there also exists a major difference between children and adults regarding treatment and development of new oncology therapies. The prominent variation is the concept of survival. With adult cancer patients, it is acceptable to look to immediate, 5 and 10-year survival rates, along with quality of life, for the best approximations of therapeutic success. On the other hand, a child cancer patient receives treatment to be cured. A typical difference between adult and pediatric oncologists is in treatment protocols; pediatric protocols are much more vigorous, often hitting patients ?as hard as possible? to achieve a successful, long-term cure.

Paediatric Oncology Therapeutics Market contains market size and forecasts of Paediatric Oncology Therapeutics in Global, including the following market information:

Global Paediatric Oncology Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Paediatric Oncology Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

By Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Paediatric Oncology Therapeutics include St Jude Children?s Research Hospital, St Louis Children?s Hospital, Monroe Carell Jr. Children?s Hospital at Vanderbilt, Birmingham Children?s Hospital, Royal Children?s Hospital, National Center for Child Health and Development and Dana-Dwek Children?s Hospital, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Paediatric Oncology Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Paediatric Oncology Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Paediatric Oncology Therapeutics Market Segment Percentages, by Type, 2021 (%)

By Treatment

Chemotherapy

Radiotheraphy

Tumor Surgery

Blood and Marrow Transplantation

Drug Therapy

By Indication

Leukemia

Central Nervous System (CNS) disorders

Bone Tumors

Inflammatory disorders

Respiratory disorders

Retinoblastoma

Global Paediatric Oncology Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Paediatric Oncology Therapeutics Market Segment Percentages, by Application, 2021 (%)

0-15 Years Old

15-19 Years Old

Global Paediatric Oncology Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Paediatric Oncology Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Paediatric Oncology Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Paediatric Oncology Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

St Jude Children?s Research Hospital

St Louis Children?s Hospital

Monroe Carell Jr. Children?s Hospital at Vanderbilt

Birmingham Children?s Hospital

Royal Children?s Hospital

National Center for Child Health and Development

Dana-Dwek Children?s Hospital